The European Union (EU) has approved Avastin, made by Swiss drug manufacturer Roche Holding AG, for use in patients with advanced non-small cell lung cancer (NSCLC).
Discuss   Add this link to...  Tell a friend   Bury

Comments Who Voted Related Links